CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Top player positioning
3.4.Porter’s five forces analysis
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Rise in incidence of chronic diseases
3.5.1.2.Surge in geriatric population across Vietnam
3.5.2.Restraint
3.5.2.1.Lack of awareness of nutrition problems among Vietnamese
3.5.3.Opportunity
3.5.3.1.Rise in medical tourism in Vietnam
3.6.List of key brands, by product type
3.7.List of key players, by product type
3.8.Average selling price, by product type
3.9.Vietnam key cities data
3.10.Impact analysis of COVID-19 on market
3.10.1.Overview
3.10.2.Impact on the market
CHAPTER 4:VIETNAM MEDICAL NUTRITION MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Infant Nutrition
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.3.Parenteral Nutrition
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by type
4.3.2.1.Dextrose based Products
4.3.2.1.1.Market size and forecast
4.3.2.2.Fat based Products
4.3.2.2.1.Market size and forecast
4.3.2.3.Additives based Products
4.3.2.3.1.Market size and forecast
4.3.3.Market size and forecast
4.4.Enteral Nutrition
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by type
4.4.2.1.Standardized
4.4.2.1.1.Market size and forecast
4.4.2.2.Semi Elemental
4.4.2.2.1.Market size and forecast
4.4.2.3.Specialized
4.4.2.3.1.Market size and forecast
4.4.3.Market size and forecast
CHAPTER 5:VIETNAM MEDICAL NUTRITION MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Diabetes
5.2.1.Market size and forecast
5.3.Cancer
5.3.1.Market size and forecast
5.4.Gastrointestinal Diseases
5.4.1.Market size and forecast
5.5.Chronic Kidney Disease
5.5.1.Market size and forecast
5.6.Chronic Liver Disease
5.6.1.Market size and forecast
5.7.Intensive Care
5.7.1.Market size and forecast
5.8.Chronic Obstructive Pulmonary Disease
5.8.1.Market size and forecast
5.9.Others
5.9.1.Market size and forecast
CHAPTER 6:VIETNAM MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL
6.1.Overview
6.1.1.Market size and forecast
6.2.Hospital Pharmacies
6.2.1.Market size and forecast
6.3.Drug Store & Retail Pharmacies
6.3.1.Market size and forecast
6.4.Online Pharmacies
6.4.1.Market size and forecast
CHAPTER 7:VIETNAM MEDICAL NUTRITION MARKET, BY END USER
7.1.Overview
7.1.1.Market size and forecast
7.2.Private Hospitals
7.2.1.Market size and forecast
7.3.Public Hospitals
7.3.1.Market size and forecast
7.4.Homecare
7.4.1.Market size and forecast
CHAPTER 8:COMPANY PROFILES
8.1.ABBOTT LABORATORIES
8.1.1.Product portfolio
8.1.2.Business performance
8.1.3.Key strategic moves and developments
8.2.B. BRAUN MELSUNGEN AG
8.2.1.Product Portfolio
8.2.2.Business performance
8.3.BAXTER INTERNATIONAL INC.
8.3.1.Product Portfolio
8.3.2.Business performance
8.4.FRESENIUS SE & CO. KGAA
8.4.1.Product portfolio
8.4.2.Business performance
TABLE 01.LIST OF KEY BRANDS, BY PRODUCT TYPE
TABLE 02.LIST OF KEY PLAYERS, BY PRODUCT TYPE
TABLE 03.AVERAGE SELLING PRICE, BY PRODUCT TYPE
TABLE 04.VIETNAM KEY CITIES DATA
TABLE 05.VIETNAM MEDICAL NUTRITION MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 06.VIETNAM MEDICAL NUTRITION MARKET FOR PARENTERAL NUTRITION, BY TYPE, 2019–2027 ($MILLION)
TABLE 07.VIETNAM MEDICAL NUTRITION MARKET FOR ENTERAL NUTRITION, BY TYPE, 2019–2027 ($MILLION)
TABLE 08.VIETNAM MEDICAL NUTRITION MARKET, BY APPLICATION 2019-2027($MILLION)
TABLE 09.VIETNAM MEDICAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2019–2027 ($MILLION)
TABLE 10.VIETNAM MEDICAL NUTRITION MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 11.ABBOTT: PRODUCT PORTFOLIO
TABLE 12.B. BRAUN: PRODUCT PORTFOLIO
TABLE 13.FRESENIUS: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.TOP INVESTMENT POCKETS, 2019
FIGURE 02.TOP PLAYER POSITIONING, 2019
FIGURE 03.LOW BARGAINING POWER OF SUPPLIERS
FIGURE 04.HIGH BARGAINING POWER OF BUYERS
FIGURE 05.MODERATE THREAT OF SUBSTITUTION
FIGURE 06.MODERATE THREAT OF NEW ENTRANT
FIGURE 07.HIIGH COMPETITIVE RIVALRY
FIGURE 08.MEDICAL NUTRITION MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 09.INFANT NUTRITION MARKET, 2019–2027 ($MILLION)
FIGURE 10.PARENTERAL NUTRITION MARKET FOR DEXTROSE BASED PRODUCTS, 2019-2027 ($MILLION)
FIGURE 11.PARENTERAL NUTRITION MARKET FOR FAT BASED PRODUCTS, 2019-2027 ($MILLION)
FIGURE 12.PARENTERAL NUTRITION MARKET FOR ADDITIVES BASED PRODUCTS, 2019-2027 ($MILLION)
FIGURE 13.PARENTERAL NUTRITION MARKET, 2019–2027 ($MILLION)
FIGURE 14.ENTERAL NUTRITION MARKET FOR STANDARDIZED, 2019-2027 ($MILLION)
FIGURE 15.ENTERAL NUTRITION MARKET FOR SEMI ELEMENTAL, 2019-2027 ($MILLION)
FIGURE 16.ENTERAL NUTRITION MARKET FOR SPECIALIZED, 2019-2027 ($MILLION)
FIGURE 17.ENTERAL NUTRITION MARKET, 2019–2027 ($MILLION)
FIGURE 18.VIETNAM MEDICAL NUTRITION MARKET FOR DIABETES, 2019–2027 ($MILLION)
FIGURE 19.VIETNAM MEDICAL NUTRITION MARKET FOR CANCER, 2019–2027 ($MILLION)
FIGURE 20.VIETNAM MEDICAL NUTRITION MARKET FOR GASTROINTESTINAL DISEASES, 2019–2027 ($MILLION)
FIGURE 21.VIETNAM MEDICAL NUTRITION MARKET FOR CHRONIC KIDNEY DISEASE, 2019–2027 ($MILLION)
FIGURE 22.VIETNAM MEDICAL NUTRITION MARKET FOR CHRONIC LIVER DISEASE, 2019–2027 ($MILLION)
FIGURE 23.VIETNAM MEDICAL NUTRITION MARKET FOR INTENSIVE CARE, 2019–2027 ($MILLION)
FIGURE 24.VIETNAM MEDICAL NUTRITION MARKET FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019–2027 ($MILLION)
FIGURE 25.VIETNAM MEDICAL NUTRITION MARKET FOR OTHERS, 2019–2027 ($MILLION)
FIGURE 26.VIETNAM MEDICAL NUTRITION MARKET FOR HOSPITAL PHARMACIES, 2019–2027 ($MILLION)
FIGURE 27.VIETNAM MEDICAL NUTRITION MARKET FOR DRUG STORE & RETAIL PHARMACIES, 2019–2027 ($MILLION)
FIGURE 28.VIETNAM MEDICAL NUTRITION MARKET FOR ONLINE PHARMACIES, 2019–2027 ($MILLION)
FIGURE 29.VIETNAM MEDICAL NUTRITION MARKET FOR PRIVATE HOSPITALS, 2019–2027 ($MILLION)
FIGURE 30.VIETNAM MEDICAL NUTRITION MARKET FOR PUBLIC HOSPITALS, 2019–2027 ($MILLION)
FIGURE 31.VIETNAM MEDICAL NUTRITION MARKET FOR HOMECARE, 2019–2027 ($MILLION)
FIGURE 32.ABBOTT: NET SALES, 2017–2019 ($MILLION)
FIGURE 33.ABBOTT: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 34.ABBOTT: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 35.NET SALES, 2017–2019 ($MILLION)
FIGURE 36.B. BRAUN: NET SALES BY DIVISION, 2019 (%)
FIGURE 37.B. BRAUN: NET SALES BY REGION, 2019 (%)
FIGURE 38.NET SALES, 2017–2019 ($MILLION)
FIGURE 39.BAXTER: REVENUE SHARE BY BUSINESS SEGMENT, 2019 (%)
FIGURE 40.BAXTER: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 41.FRESENIUS: NET SALES, 2017–2019 ($MILLION)
FIGURE 42.FRESENIUS: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 43.FRESENIUS: REVENUE SHARE BY PRODUCT SEGMENT, 2019 (%)
FIGURE 44.FRESENIUS: REVENUE SHARE BY REGION, 2019(%)